MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
The Lancet Infectious Diseases in conversation with - Un pódcast de The Lancet Group
Categorías:
John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
